Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine infusion effect on post-operative delirium
IRCT20250512065695N1Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of dexmedetomidine in postoperative delirium (POD), sponsored by Mashhad University of Medical Sciences. Primary endpoint: Incidence of postoperative delirium. Started May 2025; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
postoperative delirium (POD)
Beyond the preview
Go deeper on IRCT20250512065695N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250512065695N1.